Standards of Care Topics

Size: px
Start display at page:

Download "Standards of Care Topics"

Transcription

1 Diabetes Boot Camp Class 2 Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Standards of Care Standards of Care Topics Review the 15 Standards of Care with a focus on updated standards Keeping it Patient Centered National goals and getting to target Prevention and lifestyle interventions Poll Question 1 What is the preferred approach when providing diabetes education with patients? a. Provide patient centered selfmanagement support b. Instruct all patients to meet national standards c. Highlight risk of complications when goals aren t met d. Remind them that insulin treatment can be beneficial. Page 1

2 1. Promoting Health Reducing Disparities in Populations Start with patient centered communication. Incorporate pt preferences, literacy, life experiences Treatment decisions timely, based on evidence and tailored to individual pt. Align care with Chronic Care Model to ensure proactive practice and informed, activated patient. Provide team based care, community involvement, decision support tools. 1. Strategies for Improving Care Based on a recent report by the CDC, <7% of privately insured adults with newly diagnosed diabetes from 2009 to 2012 joined a selfmanagement education and training program. Consider Chronic Care Model 1. Optimize Provider and Team Behavior 2. Support Patient Behavior Change 3. Change the Care System Chronic Care Model CCM 6 core elements for optimal diabetes care Proactive (vs reactive) care delivery system. Planned visits coordinated through a team based approach Self Management support Decision support (basing care on evidence based guidelines) Clinical information systems (registries that provide patient specific and population based support to team) Community policies and resources to support healthy lifestyles Health systems that create a culture of quality Page 2

3 Health Disparities Tailor Treatment Consider individualized care and create environmental structures to support people with: Food insecurity Cognitive dysfunction Mental illness (2 3 x s higher rates of diabetes in schizophrenia, bipolar) HIV (meds can cause pancreatic dysfunction) Health disparities related to: Ethnicity, culture, sex, socioeconomic status Poll Question 2 According to ADA 2017 Standards, who should be screened for prediabetes/ diabetes? a. JR, has family history of diabetes, BMI 22, age 39 b. MS, age 47 c. LK, smokes, has HTN age 43 d. RA, Hispanic, low HDL, avg wt 2. Classification and DM Diagnosis Pre Diabetes & Type 2 Screening Guidelines Start screening at age 45 or for anyone who is overweight (BMI 25, Asians BMI 23 ) with one or > additional risk factor: First degree relative w/ diabetes Member of a high risk ethnic population Habitual physical inactivity PreDiabetes History of heart disease Page 3

4 Diabetes 2 Who is at Risk? (ADA Clinical Practice Guidelines) Risk factors cont d HTN BP > 140/90 HDL < 35 or triglycerides > 250 baby >9 lb History Gestational Diabetes Polycystic ovary syndrome (PCOS) Other conditions assoc w/ insulin resistance: Severe obesity, acanthosis nigricans (AN) Screening for Type 2 25% of all people with diabetes are undiagnosed 50% of all Asian and Hispanic Americans are undiagnosed Most people with prediabetes are undiagnosed. The duration of glycemic burden is a strong predictor of adverse outcomes. Use Validated Diabetes Risk Test (ADA) to identify those at risk and promote behavior change action for individuals and their communities. Dentists have an excellent opportunity to find patients with undetected diabetes, since up to 30% of patients over the age of 30 seen in general dental practices have dysglycemia. Page 4

5 Test Criteria T2 Kids & Adolescents Overweight plus any two: Family history type 2 in 1 st or 2 nd degree relative Race/ethnicity Signs of insulin resistance or conditions associated with insulin resistance Maternal history of diabetes or GDM Start testing at 10 yrs or onset of puberty Recheck every 3 years or if symptoms A1c preferred screening method 3. Comprehensive Medical Evaluation, Assessment of Comorbidities It is necessary to take into account all aspects of a patient s life circumstance A team approach is important to integrate medical eval, patient engagement and lifestyle changes. 3. Initial Eval and Diabetes Management Planning Medical Evaluation 1. Classify diabetes 2. Detect diabetes complications 3. Review previous treatment and risk factor control 4. Assist in formulating a management plan 5. Provide a basis for continuing care Page 5

6 3. Initial Eval Conditions to look for Type 1 Autoimmune diseases Other conditions that may appear Type 1 /2 Depression and anxiety Obstructive sleep apnea Fatty liver disease Cancer Fractures Cognitive impairment Low Testosterone in Men Periodontal disease Hearing Impairment 3. Keep it Patient Centered it is clear that optimal diabetes management requires an organized, systematic approach and the involvement of a coordinated team of dedicated health professionals, working in an environment where patient centered care is a high priority. Coordinate care as patients transition through different stages of life. Pt Centered Collaborative Care Use communication style that: Uses active listening Elicits patients preferences and beliefs Assess literacy, numeracy and barriers to care Optimize Patient health outcomes Health related quality of life Page 6

7 4. Lifestyle Management Education Setting Up Successful Diabetes Ed Program Level 2 Nutrition Physical Activity Smoking Cessation Psychosocial Care Immunization 4. Lifestyle Management Patients with prediabetes Refer to behavioral counseling /DSME program to: Focus on intensive diet and physical activity Weight loss target of 7% Increase physical activity to 150 minutes a week Follow up counseling critical for success Consider Metformin for type 2 prevention if A1c Especially with BMI >35 and hx of GDM Monitor annually and screen and mitigate modifiable CV risk factors Poll Question 3 What are the ADA current exercise recommendations? a. Walk daily for 30 minutes b. 30 minutes activity 5xs a week plus daily strengthening exercises c. 10 minutes of activity three times daily. d. 30 minutes activity 5xs a week plus strengthening exercises 2 3 times /wk Page 7

8 Physical Activity Children with diabetes 60 mins / day Adults 150 min/wk moderate intensity over 3 days a week. Don t miss > 2 consecutive days w/out exercise Get up every 30 mins Reduce sedentary time T1 and T2 resistance training 2 3 xs a week Flexibility and balance training 2 3 xs a week (Yoga and Tai Chi) 4. Goals of Medical Nutrition Therapy ADA Promote and support healthful eating patterns Emphasize eating a variety of nutrient dense foods in appropriate portions to: Attain individualized B/P, BG and lipid goals Attain and maintain body wt goals Delay and/or prevent complications Address individual nutrition needs based on personal and cultural preferences, access to food, willingness and barriers Maintain pleasure of eating by providing positive messages about food Limit food choices only when backed by science Provide practical tools for day to day planning 4. E Cigarettes Not supported as an alternative to smoking or to facilitate smoking cessation. Encourage all patients not to use cigarettes, other tobacco products, e cigs Provide counseling The uptake of e-cigarettes, which use battery-powered cartridges to produce a nicotine-laced vapor (and often contain other bad stuff) Page 8

9 4. Smoking Smoking and Diabetes and Diabetes Smoking increases risk of diabetes 30% Ask at every visit Assess Advise Assist with stop smoking Arrange for referrals Organize your clinic Vaccinations Immunizations Influenza vaccine every year starting at age 6 months Hepatitis B Vaccine For diabetes pts age (not previously vaccinated) Double risk of Hep B due to lancing devices/ glucose meter exposure Pneumonia Vaccinations Pneumonia polysaccharide PPSV23 vaccine to all patients starting at age 2 Adults 65 years of age, if not previously vaccinated, should receive pneumococcal conjugate vaccine 13 (PCV13), followed by PPSV months after initial vaccination. Adults 65 years of age, if previously vaccinated with PPSV23 should receive a follow up 12 months with PCV13. Page 9

10 Psychosocial Care Provide to all pts with diabetes Integrate with a collaborative, pt centered approach. Routinely screen for depression, diabetes distress, anxiety, disordered eating and cognitive capacities Evaluate adults over 65 years for cognitive impairment and depression 5. Prevention of Diabetes Medicare will start funding approved Diabetes Prevention Programs 2018 Poll Question 4 According to the Diabetes Prevention Trial, losing 5 7 % of body wt and accumulating 150 minutes activity a week can: a. Help prevent type 1 diabetes b. Lower risk of getting prediabetes c. Decrease risk of getting diabetes d. Prevent type 2 diabetes Page 10

11 Can we stop pre diabetes from progressing? 3, 234 people w/ Pre Diabetes randomized: Placebo Diet/Exercise or Metformin over a three year period Diabetes Prevention Program (DPP) 2001 CDC Diabetes Prevention Program Standard Group 29% developed DM Lifestyle Results 14% developed DM 58% (71% for 60yrs +) Risk reduction 30 mins daily activity 5 7% of body wt loss Metformin 850 BID 22% developed DM 31% risk reduction (less effective with elderly and thinner pt s) Have Pre Diabetes? Steps to Prevent Type 2 Lose 7% of body weight Healthy eating, high fiber, low fat, avoid sugar sweetened beverages, reduce total caloric intake Exercise 150 minutes a week Consider Metformin Therapy for Women with history of GDM Patients with BMI of 35 or greater Under the age of 60 Follow up and group education Annual monitoring and tx of CVD risk factors Page 11

12 DSM Education & Support All people with diabetes and pre diabetes should receive DSME at diagnosis and as needed Pt centered, respectful, responsive to individual pt preferences, needs, values Address psychosocial issues and emotional well being Effective self management results in cost savings, improved outcomes, health status and quality of life. Should be monitored as part of care 6. Glycemic Targets A1C Blood Pressure Cardiovascular risk reduction 6. Glycemic Targets Adult non pregnant A1c goals A1c < 7% a reasonable goal for adults. A1c < 6.5% may be appropriate for those without significant risk of hypoglycemia or other adverse effects of treatment. A1c < 8% may be appropriate for patients with history of hypoglycemia, limited life expectancy, or those with longstanding diabetes and vascular complications. Frequency: If pt meeting goal At least 2 times a year If pts not meeting goal Quarterly Page 12

13 6. A1c and Estimated Avg Glucose (eag) A1c (%) eag Order teaching tool kit free at diabetes.org eag = 28.7 x A1c 46.7 ~ 29 pts per 1% Translating the A1c Assay Into Estimated Average Glucose Values ADAG Study Diabetes Care: 31, #8, August A1c Test Measures glycation of RBC s over 2 3 months Weighted mean (50% preceding month) Each 1% ~ 29mg/dl Accuracy: affected by some anemias, hemoglobinopathies A measurement of glucose in fasting and postprandial states African Americans may have false lows 6. Pediatric Glycemic Targets A1c goal <7.5 % for all ages; however individualization is still encouraged. A lower goal, <7% if can be achieved w/out excessive hypoglycemia Blood glucose goals Before meals: Bedtime/overnight: Page 13

14 Poll Question 5 According to the American Association of Clinical Endo (AACE), what is the A1c goal? a. Less than 6.5 for all patients b. Pre meal blood glucose less than 110 c. A1c less than 7% d. A1c less than 6.5 for healthy patients American Association Clinical Endo (AACE) Fructosamine Test Just in case The level of fructosamine in the blood is a reflection of glucose levels over the previous 2 3 weeks Can be used to eval: Effects of rapid changes in diabetes treatment Diabetes control during pregnancy to help monitor and accommodate shifting glucose, insulin, or other medication requirements. Glucose control for pts with shortened RBC life span such as anemia or blood loss. In these situations, A1c result is falsely low. Abnormal forms of hemoglobin such as in sickle cell anemia. Page 14

15 Glucose Goals Individualize Targets ADA Pre Prandial BG hr post prandial < than 180 *for nonpregnant adults Poll Question 6 Which study demonstrated that keeping A1c less than 7% reduces complications for Type 1? a. Diabetes Prevention Trial b. Diabetes Control and Complications Trial c. United Kingdom Prospective Diabetes Study d. YOUTH Trial Diabetes Control and Complications Trial (DCCT) In June, 1993 the New England Journal of Medicine published the results of the landmark DCCT. The largest, most comprehensive diabetes study ever conducted. The 10 year study involved more than 1400 subjects with Type 1 DM. It compared the effects of two treatment regimens standard therapy and intensive control on the complications of diabetes. Page 15

16 DCCT Conclusions By maintaining A1C < 7%: Eye disease 76% reduced risk Kidney disease 50% reduced risk Nerve disease 60% reduced risk Management elements included: SMBG 4 or more times a day 4 daily insulin injections or insulin pump Greater risk of hypoglycemia UKPDS Results United kingdom Prospective Diabetes Study Conducted over 20 years involving over 5,100 patients with Type 2 diabetes 1% decrease in A 1 c reduces microvascular complications by 35% 1% decrease in A 1 c reduces diabetes related deaths by 25% B/P control (144/82) reduced risk of: Heart failure (56%) Stroke (44%) Death from diabetes (32%) Lancet 352: , 1998 Legacy Effect For participants of DCCT and UKPDS long lasting benefit of early intensive BG control prevents microvascular complications Macrovascular complications (15 55% decrease) Even though their BG levels increased over time Message Catch early and Treat aggressively Page 16

17 7. Obesity Treatment This section incorporates bariatric surgery, assessment of weight and the treatment of overweight and obesity through behavior and pharmacotherapy. Will cover in BootCamp 6 At each pt encounter, calculate BMI and document in medical record Poll Question 7 According to the ADA and AACE, which of the following diabetes med class is the first choice? a. Sulfonylureas b. GLP 1 Receptor Agonists c. SGLT 2 Inhibitors d. Biguanides Section 8 Pharmacologic Approaches to Glycemic Treatment Cover content in Boot Camp 5 Page 17

18 9. Cardiovascular Disease and Risk Management Cardiovascular disease is the leading cause of mortality and morbidity in diabetes Largest contributor to direct and indirect costs Controlling cardiovascular risk improves outcomes Large benefits are seen when multiple risk factors are addressed globally 9. BP Goal BP < 140 / 90 Some pts may benefit from B/P 130/80 (younger and achieved with undue tx burden) Studies indicate that the previous B/P target of 140/80 didn t improve outcomes enough to balance the risk of side effects such as orthostatic hypotension and polypharmacy. 9. Hypertension Guidelines Screening Check BP at each visit. If either systolic 140 or > diastolic 90 or > repeat on separate day. Hypertension = Repeat systolic or diastolic above or equal to these levels When taking B/P Pt sit still for 5 min s Feet on floor, Arm supported at heart level Right size cuff Page 18

19 9. BP Treatment ADA Standards Pts with B/P > 120/80 encourage lifestyle changes to reduce B/P B/P > 140/90 Lifestyle plus prompt initiation of B/P meds Lifestyle = Weight loss DASH Style diet (fresh fruit, veggies, whole grains, reducing sodium and increasing potassium intake) Moderation of alcohol intake Increased physical activity 9. Blood Pressure Treatment First Line B/P Drugs Any of the 4 classes of BP meds can be used to tx hypertension (without albuminuria). This includes ACE Inhibitors, ARBs, thiazide like diuretics or calcium channel blockers. Multiple Drug Therapy often required For best effect, administer at least one at bedtime 8. Dyslipidemia Screening Adults Screening lipid profile is recommended at time of diagnosis And/or at 40 years And periodically thereafter (every 1 2 years) Page 19

20 8. Dyslipidemia Management Start with lifestyle Reduce trans, saturated fat, cholesterol Increase intake of omega 3 fatty acids, viscous fiber, and plant stanols/sterols Contained in grains, vegetables, fruits, legumes, nuts, and seeds. Also added to margarine, OJ and other food products Lose weight (if indicated) Get Active 8. Dyslipidemia Management Intensify lifestyle therapy and optimize glucose control for patients with: Triglycerides 150 and/or HDL 40 (men) 50 (women) Most Pts Need a Statin Statin lowers cholesterol production in liver Ezetimibe (Zetia) blocks absorption of cholesterol in intestine Page 20

21 Statin Therapy High intensity statins (lowers LDL 50%): Lipitor (atorvastatin) 40 80mg Crestor (rosuvastatin) 20 40mg Moderate intensity (lowers LDL 30 50%) Lipitor (atorvastatin) 10 20mg Crestor (rosuvastatin) 5 10mg Zocor (Simvastatin) 20 40mg Pravachol (pravastatin) 40 80mg Mevacor (lovastatin) 40 mg Lescol (fluvastatin) XL 80mg Livalo (pitavastatin) 2 4mg Antiplatelet Agents Consider aspirin therapy ( mg/day) As a primary prevention strategy for T1 or T2 at increase CV risk (10 yr risk >10%) In pts who can t tolerate, use Plavix, (clopidogrel) Combo therapy of aspirin + clopidogrel is reasonable for a year after MI Includes most men or women w DM age 50 years, with at least 1 additional risk factor: Family history of premature ASCVD Hypertension Smoking Dylipidemia Albuminuria 8. Coronary Heart Disease In pts with known CVD, use: Aspirin Statin B/P Med Consider ACE Inhibitor to reduce risk of CV event In pts with prior MI, Beta Blockers should be continued at least 2 years after the event Don t use Actos or Avandia in pts with CHF In pts with stable CHF, Metformin can be used in renal function normal and stable Page 21

22 A 78 yr old man, smokes ppd A1c was 8.1% (down from 10.4%) B/P 136/76 AM BG 100, 2 hr pp 190 Chol TG 54, HDL 46, LDL 98 Meds: Insulin 16 units Lantus at HS Benazepril 20 mg Metoprolol 50mg Actos 15 mg Daily aspirin What class of meds is this patient on? Any special instructions? Any med missing? Poll Question 8 78 year old, A1c 8.1, LDL 98, smokes ppd. Based on ADA guidelines, what med is missing? a. Sulfonylurea b. Vitamin D c. SGLT2 Inhibitor d. Statin Diabetes Care Guidelines ADA Test / Exam Frequency A1c At least twice a year B/P Each diabetes visit Cholesterol (HDL, Tri) Yearly (less if normal) Weight each diabetes visit Microalbumin/GFR/Creat Yearly Eye exam Yearly Dental Care At least twice a year Comprehensive Foot Exam Yearly (more if high risk) Physical Activity Plan As needed to meet goals Preconception counseling As needed Page 22

23 ABCs of Diabetes A1c less than 7% (avg 3 month BG) Pre meal BG Post meal BG <180 Blood Pressure < 140/90 Cardiovascular risk reduction Eval if statin therapy indicated Mr. Jones What are Your Recommendations for Self Care? Patient Profile 62 yr old with newly dx type 2. History of previous MI. Meds: Lasix, synthroid Labs: A1c 9.3% HDL 37 mg/dl LDL 156 mg/dl Triglyceride 260mg/dl Proteinuria neg B/P 142/92 Self Care Skills Walks dog around block 3 x s a week Bowls every Friday Widowed, so usually eats out See Courses in Level 2 for following Topics for Standards Page 23

24 10. Microvascular Complications "Every time you see your doctor, take off your shoes and socks and show your feet!" For patients with loss of protective sensation, foot deformities, or a history of foot ulcers Comprehensive foot eval each year to identify risk & promote prevention 10. Microvascular Complications Nephropathy Diabetic Kidney Disease Optimize glucose and B/P Control to protect kidneys Screen for Albumin Creat ratio and GFR Type 2 at dx then yearly Type 1 with diabetes for 5 years, then yearly Treat hypertension with ACE or ARB and intensify as needed Consider referral to specialist when management is difficult and kidney disease is advanced Not recommended to limit dietary protein intake below 0.8 g/kg/day (doesn t improve outcomes) See Level 2 Course, Microvascular Complications 10. Microvascular Complications Eye Disease Optimize glucose and B/P Control to protect eyes Screen with initial dilated and comprehensive eye exam by ophthalmologist or optometrist Type 2 at diagnosis, then every one to 2 years Type 1 within 5 years of dx, then every 1 2 years Can use high quality fundus photography as screening tool Initial exam should be done in person Promptly refer pts with macular edema, severe non proliferative disease trained specialist Treatment includes laser therapy (retinopathy) and Antivascular and Endothelial Growth Factor for Macular Edema Page 24

25 10. Microvascular Complications Nerve Disease Tight glycemic control Medication recommendations updated Screen all patients for nerve disease using simple tests, such as a monofilament Type 2 at diagnosis, then annually Type 1 diabetes 5 years, then annually Assess and treat patients to reduce pain and symptoms to improve quality of life. 11. Older Adults 26% of people over 65 have diabetes (expected to rise) Asses the medical, functional, mental and social geriatric domains for diabetes. Provide individualized care Determine targets and therapeutic approaches Over age 65, high risk for depression Provide nursing home staff with education See Level 2 Course, Older Adults and Diabetes Older Adults ( 65 years) with diabetes Annual screening for early detection of mild cognitive impairment or dementia High priority population for depression screening and treatment Avoid hypoglycemia in this high risk group Prevent hypo by adjusting glycemic targets and adjusting pharmacologic interventions Page 25

26 12. Children and Adolescents Start preconception counseling at puberty for all girls of childbearing potential decreases risk of malformations associated with unplanned pregnancies and poor metabolic control, Type 1 or Type 2 Diabetes? Many children are overweight with new See Level 2 Course - Kids hyperglycemia. and Diabetes for full detail 6% of children with new type 2 present in DKA. Type 2 in kids is different than type 2 in adults, including more rapid decline in beta cell function and accelerated development of diabetes complications. Evaluate autoantibodies and do a careful history to determine the correct diagnosis and provide early and appropriate treatment. 13. Gestational DM ~ 7% of all Pregnancies GDM prevalence increased by % during the past 20 yrs Native Americans, Asians, Hispanics, African American women at highest risk Immediately after pregnancy, 5% to 10% of GDM diagnosed with type 2 diabetes Within 5 years, 50% chance of developing DM in next 5 years. 13. Meds used in Pregnancy Insulin is the preferred med to be used in pregnancy Glyburide and Metformin cross the placenta Long term studies needed Page 26

27 14. Diabetes Care in Hospital, Nursing Home and Skilled Nursing Facility Get A1c on all patient with DM/hyperglycemia Start discharge planning on admission Avoid sole use of sliding scale insulin during hospital stay Basal bolus preferred treatment Have hypoglycemia protocol Clearly identify type of diabetes on admission Inpatient glucose goals: Start insulin if BG >180 Goal BG (some pts may benefit from ) New Parenteral/Enteral Feeding Chart 15. Diabetes Advocacy People living with diabetes should not face discrimination We need to all be a part of advocating for the best care and the rights of people living with diabetes. Thank You us with any questions. View recorded webcasts and take post test and survey at Thank you! Page 27

DM Fundamentals Class 5 Goals & Standards of Care Standards of Care Topics. CDE Coach App Download Success

DM Fundamentals Class 5 Goals & Standards of Care Standards of Care Topics. CDE Coach App Download Success DM Fundamentals Class 5 Goals & Standards of Care 2017 Beverly Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Standards of Care Topics Review the 15 Standards of Care with a focus

More information

Welcome to Diabetes MiniSeries Course 2

Welcome to Diabetes MiniSeries Course 2 Welcome to Diabetes MiniSeries Course 2 Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Copyright 1999 2014, Diabetes Education Services, All Rights Reserved. Diabetes

More information

Clinical Practice Guidelines for Diabetes Management

Clinical Practice Guidelines for Diabetes Management Clinical Practice Guidelines for Diabetes Management Diabetes is a disease in which blood glucose levels are above normal. Over the years, high blood glucose damages nerves and blood vessels, which can

More information

Standards of Medical Care In Diabetes

Standards of Medical Care In Diabetes Standards of Medical Care In Diabetes - 2017 Robert E. Ratner, MD, FACP, FACE Professor of Medicine Georgetown University School of Medicine Disclosed no conflict of interest Standards of Care Professional.diabetes.org/SOC

More information

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures

More information

Standards of Medical Care in Diabetes 2018

Standards of Medical Care in Diabetes 2018 Standards of Medical Care in Diabetes 2018 Eric L. Johnson, M.D. Associate Professor University of North Dakota School of Medicine and Health Sciences Assistant Medical Director Altru Diabetes Center Grand

More information

American Diabetes Association: Standards of Medical Care in Diabetes 2015

American Diabetes Association: Standards of Medical Care in Diabetes 2015 American Diabetes Association: Standards of Medical Care in Diabetes 2015 Synopsis of ADA standards relevant to the 11 th Scope of Work under Task B.2 ASSESSMENT OF GLYCEMIC CONTROL Recommendations: Perform

More information

Standards of Medical Care in Diabetes 2016

Standards of Medical Care in Diabetes 2016 Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking

More information

STATE OF THE STATE: TYPE II DIABETES

STATE OF THE STATE: TYPE II DIABETES STATE OF THE STATE: TYPE II DIABETES HENRY DRISCOLL, MD, CHIEF of ENDOCRINOLOGY MARSHALL U, CHERTOW DIABETES CENTER, HUNTINGTON VAMC HEATHER VENOY, RD, LD, CDE DIETITIAN, DIABETES EDUCATOR, CHERTOW DIABETES

More information

Modified version focused on CCNC Quality Measures and Feedback Processes

Modified version focused on CCNC Quality Measures and Feedback Processes Executive Summary: Standards of Medical Care in Diabetes 2010 Modified version focused on CCNC Quality Measures and Feedback Processes See http://care.diabetesjournals.org/content/33/supplement_1/s11.full

More information

American Diabetes Association 2018 Guidelines Important Notable Points

American Diabetes Association 2018 Guidelines Important Notable Points American Diabetes Association 2018 Guidelines Important Notable Points The Standards of Medical Care in Diabetes-2018 by ADA include the most current evidencebased recommendations for diagnosing and treating

More information

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient

More information

STANDARDS OF MEDICAL CARE IN DIABETES 2014

STANDARDS OF MEDICAL CARE IN DIABETES 2014 STANDARDS OF MEDICAL CARE IN DIABETES 2014 I. CLASSIFICATION AND DIAGNOSIS Classification of Diabetes Type 1 diabetes β-cell destruction Type 2 diabetes Progressive insulin secretory defect Other specific

More information

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents

More information

Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018

Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018 Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018 Points to Ponder ASCVD is the leading cause of morbidity

More information

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes

More information

Key Elements in Managing Diabetes

Key Elements in Managing Diabetes Key Elements in Managing Diabetes Presentor Disclosure No conflicts of interest to disclose Presented by Susan Cotey, RN, CDE Lennon Diabetes Center Stephanie Tubbs Jones Health Center Cleveland Clinic

More information

What s New in the Standards of Medical Care in Diabetes? Dr. Jason Kruse, DO Broadlawns Medical Center

What s New in the Standards of Medical Care in Diabetes? Dr. Jason Kruse, DO Broadlawns Medical Center What s New in the Standards of Medical Care in Diabetes? Dr. Jason Kruse, DO Broadlawns Medical Center Learning Objectives By the end of this presentation, participants should be able to: Discuss updates

More information

Executive Summary: Standards of Medical Care in Diabetes 2010

Executive Summary: Standards of Medical Care in Diabetes 2010 E X E C U T I V E S U M M A R Y Executive Summary: Standards of Medical Care in Diabetes 2010 Current criteria for the diagnosis of diabetes A1C 6.5%: The test should be performed in a laboratory using

More information

Adult Diabetes Clinician Guide NOVEMBER 2017

Adult Diabetes Clinician Guide NOVEMBER 2017 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Adult Diabetes Clinician Guide Introduction NOVEMBER 2017 This evidence-based guideline summary is based on the 2017 KP National Diabetes Guideline.

More information

Diabetes Complications Guideline Based Screening, Management, and Referral

Diabetes Complications Guideline Based Screening, Management, and Referral Diabetes Complications Guideline Based Screening, Management, and Referral Eric L. Johnson, M.D. Associate Professor Department of Family and Community Medicine Assistant Medical Director Altru Diabetes

More information

Diabetes Summary of Medical Guidelines

Diabetes Summary of Medical Guidelines Diabetes Summary of Medical Guidelines Key concepts in setting glycemic controls: goals should be individualized; certain populations (children, pregnant women, and elderly) require special considerations;

More information

Diabetes Mellitus: Evaluation and Care Management

Diabetes Mellitus: Evaluation and Care Management Diabetes Mellitus: Evaluation and Care Management Michael King, MD Assistant Professor Residency Program Director University of Kentucky Dept. of Family & Community Medicine Learning Objectives 1. Review

More information

Long-Term Complications of Diabetes Mellitus Macrovascular Complication

Long-Term Complications of Diabetes Mellitus Macrovascular Complication Long-Term Complications of Diabetes Mellitus Macrovascular Complication Sung Hee Choi MD, PhD Professor, Seoul National University College of Medicine, SNUBH, Bundang Hospital Diabetes = CVD equivalent

More information

American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates

American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates Juan Pablo Frias, MD President and CEO, National Research Institute, Los Angeles, CA Clinical Faculty, University

More information

American Diabetes Association Standards of Medical Care in Diabetes 2017: Focus on Complications

American Diabetes Association Standards of Medical Care in Diabetes 2017: Focus on Complications American Diabetes Association Standards of Medical Care in Diabetes 2017: Focus on Complications Juan Pablo Frias, M.D., FACE President and CEO, National Research Institute, Los Angeles, CA Clinical Faculty,

More information

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet

More information

Diabetes Review Chris Paras, D.O. Assistant Prof of Medicine, NYIT & Touro COM Designated Institutional Official & Assoc. Clinical Dean, Brookdale

Diabetes Review Chris Paras, D.O. Assistant Prof of Medicine, NYIT & Touro COM Designated Institutional Official & Assoc. Clinical Dean, Brookdale Diabetes Review Chris Paras, D.O. Assistant Prof of Medicine, NYIT & Touro COM Designated Institutional Official & Assoc. Clinical Dean, Brookdale University Hospital Diabetes Care 2018 Jan; 41 Objectives

More information

DIABETES MEASURES GROUP OVERVIEW

DIABETES MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: DIABETES MEASURES GROUP OVERVIEW 2014 PQRS MEASURES IN DIABETES MEASURES GROUP: #1. Diabetes: Hemoglobin A1c Poor Control #2. Diabetes: Low Density Lipoprotein (LDL-C)

More information

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE Management of DM in Older Adults: It s not all about sugar! Peggy Odegard, Pharm.D., BCPS, CDE Who needs treatment for DM? 87 year old, frail male with moderately severe dementia living in NH with persistent

More information

Diabetes and the Heart

Diabetes and the Heart Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with

More information

Diabetes and Hypertension

Diabetes and Hypertension Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for

More information

Diabetes Update: Diabetes Management In Primary Care. Jonathon M. Firnhaber, MD, FAAFP

Diabetes Update: Diabetes Management In Primary Care. Jonathon M. Firnhaber, MD, FAAFP Diabetes Update: Diabetes Management In Primary Care Jonathon M. Firnhaber, MD, FAAFP Learning objectives 1. Critically evaluate the evidence emerging within diabetes research as it applies to recommendations

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

8/5/2017. Disclosure to Participants. Learning Outcomes. Terry Compton MS, APRN, CDE. Seniors with Diabetes: Why Are They Different?

8/5/2017. Disclosure to Participants. Learning Outcomes. Terry Compton MS, APRN, CDE. Seniors with Diabetes: Why Are They Different? Terry Compton MS, APRN, CDE Diabetes Education Program Manager St. Tammany Parish Hospital Covington, LA Sara (Mandy) Reece PharmD, CDE, BC-ADM, FAADE Diabetes Educator Vice Chair and Associate Professor,

More information

Diabetes Updates. Disclosures

Diabetes Updates. Disclosures Diabetes Updates Dr. Thanh D. Hoang, DO, FACP, FACE Walter Reed National Military Medical Center Associate Professor of Medicine Uniformed Services University of the Health Sciences March 2018 Disclosures

More information

Jennifer Loh, MD, FACE Chief of Endocrinology KP Hawaii AAMD of Medical Education, KP Hawaii

Jennifer Loh, MD, FACE Chief of Endocrinology KP Hawaii AAMD of Medical Education, KP Hawaii Individualized Diabetes Treatment for the Elderly Jennifer Loh, MD, FACE Chief of Endocrinology KP Hawaii AAMD of Medical Education, KP Hawaii Extremely Relevant Baby Boomers are aging! ¼ of people age

More information

Vipul Lakhani, MD Oregon Medical Group Endocrinology

Vipul Lakhani, MD Oregon Medical Group Endocrinology Vipul Lakhani, MD Oregon Medical Group Endocrinology Disclosures None Objectives Be able to diagnose diabetes and assess control Be able to identify appropriate classes of medications for diabetes treatment

More information

Sect S io ecn ti 1 o : n Trend 1: Tres nds

Sect S io ecn ti 1 o : n Trend 1: Tres nds Section 1: 1: Trends 1 Patients in the Diabetes Register 2 Gender of Patients with Diabetes 2 Age of Patients with Diabetes 3 Diabetes Type 3 Duration of Diabetes 4 Weight Control 5 Hemoglobin A1c 6 Blood

More information

Executive Summary: Standards of Medical Care in Diabetes 2009

Executive Summary: Standards of Medical Care in Diabetes 2009 Executive Summary Executive Summary: Standards of Medical Care in Diabetes 2009 Current Criteria for the Diagnosis of Diabetes Fasting plasma glucose (FPG) 126 mg/dl (7.0 mmol/l). Fasting is defined as

More information

Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for

Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for Section 1: 1: Trends 1 Patients in the Diabetes Register 2 Gender of Patients with Diabetes 2 Age of Patients with Diabetes 3 Diabetes Type 3 Duration of Diabetes 4 Weight Control 5 Hemoglobin A1c 6 Blood

More information

DIABETES. A growing problem

DIABETES. A growing problem DIABETES A growing problem Countries still grappling with infectious diseases such as tuberculosis, HIV/AIDS and malaria now face a double burden of disease Major social and economic change has brought

More information

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series Our speaker today is: Susan Vos, BSN, RN, CCM Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series We will be starting shortly A few housekeeping items: We will be

More information

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI Hypertension, Hyperlipidemia and Obesity Mi-CCSI Objectives Review the prevalence of hypertension, hyperlipidemia and obesity Correlation of the 3 conditions Discuss why it is important to treat these

More information

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes Pre-diabetes Pharmacological Approaches to Delay Progression to Diabetes Overview Definition of Pre-diabetes Risk Factors for Pre-diabetes Clinical practice guidelines for diabetes Management, including

More information

Established Risk Factors for Coronary Heart Disease (CHD)

Established Risk Factors for Coronary Heart Disease (CHD) Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland

More information

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE Standards of Care in Diabetes 2016-- What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE Terminology No longer using the term diabetic. Diabetes does not define people. People

More information

2018 Standard of Medical Care Diabetes and Pregnancy

2018 Standard of Medical Care Diabetes and Pregnancy 2018 Standard of Medical Care Diabetes and Pregnancy 2018 Standard of Medical Care Diabetes and Pregnancy Marjorie Cypress does not have any relevant financial relationships with any commercial interests

More information

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Index Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Medication GAD glutamic acid decarboxylase GLP-1 glucagon-like peptide 1 NPH neutral

More information

Session 21: Heart Health

Session 21: Heart Health Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk

More information

Update on Diabetes Standards-What Community Physicians Should Know. Kevin Miller D.O.

Update on Diabetes Standards-What Community Physicians Should Know. Kevin Miller D.O. Update on Diabetes Standards-What Community Physicians Should Know. Kevin Miller D.O. Know The ABC Targets A1C BP LDL Cholesterol AACE Recommendations for A1C Testing A1C levels may be misleading in several

More information

Page 0 of 20. Health Profiles. Diabetes Montgomery County, OH. Public Health - Dayton & Montgomery County Epidemiology Section

Page 0 of 20. Health Profiles. Diabetes Montgomery County, OH. Public Health - Dayton & Montgomery County Epidemiology Section Page 0 of 20 Health Profiles Diabetes Montgomery County, OH Public Health - Dayton & Montgomery County Epidemiology Section January 2014 Page 1 of 20 Prepared by: Epidemiology Section of Public Health

More information

Type 2 Diabetes in Adolescents

Type 2 Diabetes in Adolescents Type 2 Diabetes in Adolescents Disclosures Paid consultant, Eli Lilly, Inc, Pediatric Type 2 Diabetes Clinical Trials Outline The burden of diabetes Treatment and Prevention Youth Diabetes Prevention Clinic

More information

Nutritional Recommendations for the Diabetes Managements

Nutritional Recommendations for the Diabetes Managements In the name of God Nutritional for the Diabetes Managements Zohreh Mazloom. PhD Shiraz University of Medical Sciences School of Nutrition and Food Sciences Department of Clinical Nutrition OVERVIEW Healthful

More information

RCHC Clinical Guidelines Type 2 Diabetes; Adults

RCHC Clinical Guidelines Type 2 Diabetes; Adults RCHC Clinical Guidelines Type 2 Diabetes; Adults Screening for diabetes in asymptomatic adults 1 Population: Aged > 45 years; Aged < 45 years who are overweight (BMI> 25kg/m 2 ) and have an additional

More information

Welcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1

Welcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1 Welcome Everyone Sign-In Enjoy Breakfast Meet someone new Enter Raffle Pick a team name Please silence phones We start at 8:00am Monitoring, Sick Days, Inpatient Management - Objectives Objectives: Strategies

More information

Diabetes Audit Results, Portland Area, Site-Specific Trends

Diabetes Audit Results, Portland Area, Site-Specific Trends Site-Specific Trends The following report contains information from your program's annual diabetes audit submission to the Indian Health Service over the past few years. The report was prepared for your

More information

A Summary Report: 2003

A Summary Report: 2003 D iabetes in Idaho A Summary Report: 2003 Idaho Department of Health and Welfare Division of Health Bureau of Community and Environmental Health This publication was supported by Grant No. U32/CCU022691-02

More information

Diabetes 2013: Achieving Goals Through Comprehensive Treatment. Session 2: Individualizing Therapy

Diabetes 2013: Achieving Goals Through Comprehensive Treatment. Session 2: Individualizing Therapy Diabetes 2013: Achieving Goals Through Comprehensive Treatment Session 2: Individualizing Therapy Joshua L. Cohen, M.D., F.A.C.P. Professor of Medicine Interim Director, Division of Endocrinology & Metabolism

More information

Guiding Principles. for Diabetes Care: For Health Care. Providers

Guiding Principles. for Diabetes Care: For Health Care. Providers Guiding Principles N A T I O N A L for Diabetes Care: D I A B E T E S For Health Care E D U C A T I O N Providers P R O G R A M The National Diabetes Education Program (NDEP) has developed these Guiding

More information

SIGN 149 Risk estimation and the prevention of cardiovascular disease. Quick Reference Guide July Evidence

SIGN 149 Risk estimation and the prevention of cardiovascular disease. Quick Reference Guide July Evidence SIGN 149 Risk estimation and the prevention of cardiovascular disease Quick Reference Guide July 2017 Evidence ESTIMATING CARDIOVASCULAR RISK R Individuals with the following risk factors should be considered

More information

Overview. Diabetes epidemiology Key elements of the VA/DoD Diabetes practice guideline How to integrate the guideline into primary care

Overview. Diabetes epidemiology Key elements of the VA/DoD Diabetes practice guideline How to integrate the guideline into primary care Overview Diabetes epidemiology Key elements of the VA/DoD Diabetes practice guideline How to integrate the guideline into primary care Diabetes Population World-wide 366 million people have diabetes 18.8

More information

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG Diabetes Mellitus: Update 7 What is the unifying basis of this vascular disease? Eugene J. Barrett, MD, PhD Professor of Internal Medicine and Pediatrics Director, Diabetes Center and GCRC Health System

More information

Application of the Diabetes Algorithm to a Patient

Application of the Diabetes Algorithm to a Patient Application of the Diabetes Algorithm to a Patient Apply knowledge gained from this activity to improve disease management and outcomes for patients with T2DM and obesity Note: The cases in this deck represent

More information

9/28/2012. Sponsored By: NDSU College of Pharmacy, Nursing and Allied Sciences

9/28/2012. Sponsored By: NDSU College of Pharmacy, Nursing and Allied Sciences Sponsored By: NDSU College of Pharmacy, Nursing and Allied Sciences By PresenterMedia.com Faculty: Wendy Brown Pharm.D, PA-C, AE-C Associate Professor Pharmacy Practice About the Patient Clinical Coordinator

More information

Course Objectives. Diabetes Fundamentals Series Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services

Course Objectives. Diabetes Fundamentals Series Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Diabetes Fundamentals Series Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services 2017 Welcome to Diabetes Fundamentals Series of 6 courses designed to provide you with

More information

Clinical Practice Guideline Key Points

Clinical Practice Guideline Key Points Clinical Practice Guideline Key Points Clinical Practice Guideline 2008 Key Points Diabetes Mellitus Provided by: Highmark Endocrinology Clinical Quality Improvement Committee In accordance with Highmark

More information

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines Conflict of Interest Disclosure Updates for the Ambulatory Care Pharmacist: Dyslipidemia and CV Risk Assessment No conflicts of interest to disclose 2014 Updates to the Updates in Ambulatory Care Pharmacy

More information

Standards of Medical Care in Diabetes

Standards of Medical Care in Diabetes Standards of Medical Care in Diabetes - 2018 1. Improving Care and Promoting Health in Populations Diabetes and Population Health: Recommendations Ensure treatment decisions are timely, rely on evidence-based

More information

NEW DIABETES CARE MEDICATIONS

NEW DIABETES CARE MEDICATIONS NEW DIABETES CARE MEDICATIONS James Bonucchi DO, ECNU, FACE Adult Medicine and Endocrinology Specialists Disclosures Speakers bureau Sanofi AZ BI Diabetes Diabetes cost ADA 2017 data Ever increasing disorder.

More information

Presenter Disclosure Information

Presenter Disclosure Information Prediabetes & Type 2 Diabetes Prevention Cari Ritter, PA-C Presenter Disclosure Information In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure

More information

Why do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes?

Why do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes? What is Diabetes? Diabetes 101 Ginny Burns RN MEd CDE Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action

More information

Individualizing Type 2 Diabetes Management. Cynthia Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD

Individualizing Type 2 Diabetes Management. Cynthia Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD Individualizing Type 2 Diabetes Management Cynthia Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD Harsh Statistics 30.3 million (9.4% of population) in US had DM in 2015 The percent of population with DM increases

More information

Clinical Recommendations: Patients with Periodontitis

Clinical Recommendations: Patients with Periodontitis The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;

More information

Health Aging. Xaviour Walker MD, MPH, DTMH UCI Geriatric Fellow Hospitalist, Public Health and Preventive Medicine Physician

Health Aging. Xaviour Walker MD, MPH, DTMH UCI Geriatric Fellow Hospitalist, Public Health and Preventive Medicine Physician Health Aging Xaviour Walker MD, MPH, DTMH UCI Geriatric Fellow Hospitalist, Public Health and Preventive Medicine Physician What is Healthy Aging? Charles Eugster 96 years young! Stanislaw Kowalski 104

More information

Clinical Practice Guidelines

Clinical Practice Guidelines Clinical Practice Guidelines Diabetes Objective The purpose is to guide the appropriate diagnosis and management of Diabetes. This guideline is designed to assist the clinician by providing a framework

More information

Diabetes Mellitus in Older Adults. Presenter Disclosure Information

Diabetes Mellitus in Older Adults. Presenter Disclosure Information Diabetes Mellitus in Older Adults Medha Munshi, M.D. Joslin Diabetes Center Beth Israel Deaconess Medical Center Harvard Medical School Presenter Disclosure Information Medha Munshi Research grant from

More information

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing Hypertension and Hyperlipidemia University of Illinois at Chicago College of Nursing 1 Learning Objectives 1. Provide a basic level of knowledge regarding hypertension and hyperlipidemia and care coordinators/

More information

Utah Diabetes Practice Recommendations Diabetes Management for Adults

Utah Diabetes Practice Recommendations Diabetes Management for Adults Utah Diabetes Practice Recommendations Diabetes Management for Adults 2011 Panel Sarah Woolsey, MD, Chair, Family Medicine HealthInsight Wayne Cannon, MD, Pediatrics Intermountain Healthcare Roy Gandolfi,

More information

Diabetes Mellitus: Implications of New Clinical Trials and New Medications

Diabetes Mellitus: Implications of New Clinical Trials and New Medications Diabetes Mellitus: Implications of New Clinical Trials and New Medications Estimates of Diagnosed Diabetes in Adults, 2005 Alka M. Kanaya, MD Asst. Professor of Medicine UCSF, Primary Care CME October

More information

Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD

Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes Stephen D. Sisson MD Objectives To review dietary recommendations in the following conditions: Obesity Hypertension Diabetes

More information

Living with Diabetes

Living with Diabetes Living with Diabetes You Are Not Alone! Diabetes continues to grow each year at an alarming rate in the United States. According to the Centers for Disease Control and Prevention (CDC), nearly 30 million

More information

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of

More information

Part 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives.

Part 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes Stephen D. Sisson MD Objectives To review dietary recommendations in the following conditions: Obesity Hypertension Diabetes

More information

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN 1980 to 2000: Death rate fell from: 542.9 to 266.8 per 100K men 263.3 to 134.4 per 100K women 341,745 fewer deaths from CHD in 2000 Ford ES, NEJM, 2007 47% from CHD treatments, 44% from risk factor modification

More information

2016 Diabetes Practice Guidelines

2016 Diabetes Practice Guidelines 2016 Diabetes Practice Guidelines SOURCE(S): 1. American Diabetes Association. Standards of Medical Care in Diabetes 2016. Diabetes Care January 2016 Volume 39, Supplement 1. Diagnosis Diabetes can be

More information

= AUDIO. Managing Diabetes for Improved Cardiovascular Health. An Important Reminder. Mission of OFMQ 8/18/2015. Jimmi Norris MS, RN, CDE

= AUDIO. Managing Diabetes for Improved Cardiovascular Health. An Important Reminder. Mission of OFMQ 8/18/2015. Jimmi Norris MS, RN, CDE Managing Diabetes for Improved Cardiovascular Health Jimmi Norris MS, RN, CDE An Important Reminder For audio, you must use your phone: Step 1: Call (866) 906 0123. Step 2: Enter code 2071585#. Step 3:

More information

Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology

Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology Disclosures In compliance with the accrediting board policies, the American Diabetes Association requires the

More information

The National Diabetes Prevention Program in Washington State March 2012

The National Diabetes Prevention Program in Washington State March 2012 The National Diabetes Prevention Program in Washington State March 2012 Session Objectives 1. Overview of pre-diabetes. 2. Describe the Diabetes Prevention Program (DPP). 3. Eligibility for the DPP. 4.

More information

Physical Activity/Exercise Prescription with Diabetes

Physical Activity/Exercise Prescription with Diabetes Physical Activity/Exercise Prescription with Diabetes B R AD H I NTERMEYER C E P A C SM S A NFORD H E ALTH C A RDIAC R E H AB A N D D I ABE TES E XE RCISE The adoption and maintenance of physical activity

More information

Blood Pressure Measurement (children> 3 yrs)

Blood Pressure Measurement (children> 3 yrs) Blood Pressure Measurement (children> 3 yrs) If initial BP elevated, repeat BP manually 2x and average, then classify Normal BP Systolic and diastolic

More information

Special thanks to the EJC Foundation for their support of Sanford Center Geriatric Specialty Clinic

Special thanks to the EJC Foundation for their support of Sanford Center Geriatric Specialty Clinic Special thanks to the EJC Foundation for their support of Sanford Center Geriatric Specialty Clinic Sanford Center for Aging 775-784-4744 med.unr.edu/aging Diabetes Management Series: From Selfmanagement

More information

The American Diabetes

The American Diabetes Standards of Medical Care in Diabetes 2016 Abridged for Primary Care Providers American Diabetes Association This is an abridged version of the American Diabetes Association Position Statement: Standards

More information

Living Well with Diabetes

Living Well with Diabetes Living Well with Diabetes What is diabetes? Diabetes Overview Diabetes is a disorder of the way the body uses food for growth and energy. Most of the food people eat is broken down into glucose, the form

More information

The ABCs (A1C, BP and Cholesterol) of Diabetes

The ABCs (A1C, BP and Cholesterol) of Diabetes The ABCs (A1C, BP and Cholesterol) of Diabetes Gregg Simonson, PhD Director, Professional Training and Consulting International Diabetes Center; Adjunct Assistant Professor, University of Minnesota Department

More information

Wayne Gravois, MD August 6, 2017

Wayne Gravois, MD August 6, 2017 Wayne Gravois, MD August 6, 2017 Americans with Diabetes (Millions) 40 30 Source: National Diabetes Statistics Report, 2011, 2017 Millions 20 10 0 1980 2009 2015 2007 - $174 Billion 2015 - $245 Billion

More information

IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS

IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS Dr Bidhu Mohapatra, MBBS, MD, FRACP Consultant Physician Endocrinology and General Medicine Introduction 382 million people affected by diabetes

More information

Diabetes Mellitus Case Study

Diabetes Mellitus Case Study COLORADO STATE UNIVERSITY Diabetes Mellitus Case Study Medical Nutrition Therapy By: Emily Lancaster 9/28/2012 [Type the abstract of the document here. The abstract is typically a short summary of the

More information

National Diabetes Fact Sheet, 2011

National Diabetes Fact Sheet, 2011 National Diabetes Fact Sheet, 2011 FAST FACTS ON DIABETES Diabetes affects 25.8 million people 8.3% of the U.S. population DIAGNOSED 18.8 million people UNDIAGNOSED 7.0 million people All ages, 2010 Citation

More information

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group Primary and Secondary Prevention of Cardiovascular Disease Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group AHA Diet and Lifestyle Recommendations Balance calorie intake and physical activity to

More information